Logo image of RVMD

REVOLUTION MEDICINES INC (RVMD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RVMD - US76155X1000 - Common Stock

76.32 USD
+2.66 (+3.61%)
Last: 11/25/2025, 8:11:37 PM
75.0765 USD
-1.24 (-1.63%)
After Hours: 11/25/2025, 8:11:37 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RVMD revenue by date.RVMD revenue by date.
29.39M
-31.62%
35.38M
20.38%
11.58M
-67.27%
306K
-100.00%
3.978M25.369M
537.73%
174.76M
588.87%
764.26M
337.32%
1.587B
107.65%
2.887B
81.92%
4.783B
65.67%
6.102B
27.58%
EBITDA
YoY % growth
RVMD ebitda by date.RVMD ebitda by date.
-183.86M
-71.80%
-253.24M
-37.74%
-481.075M
-89.97%
-673.512M
-41.74%
-1.065B
-56.18%
-1.21B
-13.62%
-1.299B
-7.38%
-983.698M
24.29%
-507.868M
48.37%
533.33M
205.01%
1.622B
204.13%
2.21B
36.25%
EBIT
YoY % growth
RVMD ebit by date.RVMD ebit by date.
-188.01M
-69.84%
-258.28M
-37.38%
-487.185M
-88.63%
-680.641M
-41.53%
-1.103B
-59.90%
-1.196B
-8.46%
-1.082B
9.55%
-559.845M
48.24%
92.549M
116.53%
1.078B
1,064.79%
2.492B
131.17%
3.315B
33.03%
Operating Margin
RVMD operating margin by date.RVMD operating margin by date.
-639.71%-730.02%-4,207.12%-222,431.83%-27,715.54%-4,713.74%-618.95%-73.25%5.83%37.34%52.10%54.33%
EPS
YoY % growth
RVMD eps by date.RVMD eps by date.
-2.56
-19.63%
-3.10
-21.09%
-3.77
-21.71%
-3.54
5.38%
-5.47
-53.26%
-6.16
-12.67%
-6.00
2.72%
-2.79
53.53%
0.68
124.52%
5.48
701.28%
12.10
120.98%
14.50
19.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.63
-45.58%
-1.68
-48.94%
-1.75
-33.53%
-1.79
-10.87%
-1.44
11.67%
Revenue
Q2Q % growth
3.142M
-100.00%
EBITDA
Q2Q % growth
-334.184M
-60.14%
-341.936M
-47.21%
-354.153M
-42.28%
-363.179M
-17.55%
-219.3M
34.38%
EBIT
Q2Q % growth
-326.667M
-51.02%
-336.18M
-52.60%
-345.39M
-44.14%
-352.316M
-11.75%
-301.49M
7.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.61
-71.28%
-1.45-0.16-11.24%
Q2 2025
Q2Q % growth
-1.31
-61.73%
-1.16-0.15-12.79%
Q1 2025
Q2Q % growth
-1.13
-61.43%
-1.11-0.02-1.54%
Q4 2024
Q2Q % growth
-1.12
1.75%
-1.01-0.11-11.25%
Q3 2024
Q2Q % growth
-0.94
5.34%
-0.91-0.03-3.17%
Q2 2024
Q2Q % growth
-0.81
11.96%
-0.79-0.02-2.48%
Q1 2024
Q2Q % growth
-0.70
2.78%
-0.760.068.02%
Q4 2023
Q2Q % growth
-1.14
-80.95%
-0.90-0.24-26.70%
Q3 2023
Q2Q % growth
-0.99
-14.14%
-1.030.033.23%
Q2 2023
Q2Q % growth
-0.92
-12.20%
-0.84-0.08-9.49%
Q1 2023
Q2Q % growth
-0.72
7.69%
-0.830.1113.23%
Q4 2022
Q2Q % growth
-0.63
11.27%
-0.840.2124.84%
Q3 2022
Q2Q % growth
-0.87
-20.83%
-0.86-0.01-1.27%
Q2 2022
Q2Q % growth
-0.82
-36.67%
-0.870.055.39%
Q1 2022
Q2Q % growth
-0.78
-47.17%
-0.790.011.31%
Q4 2021
Q2Q % growth
-0.71
-36.54%
-0.65-0.06-9.01%
Q3 2021
Q2Q % growth
-0.72
-71.43%
-0.64-0.08-12.86%
Q2 2021
Q2Q % growth
-0.60
-30.43%
-0.57-0.03-5.04%
Q1 2021
Q2Q % growth
-0.53
28.38%
-0.530.000.84%
Q4 2020
Q2Q % growth
-0.52
92.02%
-0.39-0.13-32.76%
Q3 2020
Q2Q % growth
-0.42 -0.40-0.02-5.04%
Q2 2020
Q2Q % growth
-0.46 -0.37-0.09-24.58%
Q1 2020
Q2Q % growth
-0.74 -0.34-0.40-118.19%
Q4 2019
Q2Q % growth
-6.52 -0.42-6.10-1,459.06%
RVMD Yearly EPS VS EstimatesRVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.613M-1.613M-100.00%
Q2 2025
Q2Q % growth
2.867M-2.867M-100.00%
Q4 2024
Q2Q % growth

-100.00%
353.073K-353.073K-100.00%
Q3 2024
Q2Q % growth
327.859K-327.859K-100.00%
Q2 2024
Q2Q % growth

-100.00%
765K-765K-100.00%
Q1 2024
Q2Q % growth

-100.00%
1.404M-1.404M-100.00%
Q4 2023
Q2Q % growth
742K
-95.16%
1.113M-371K-33.33%
Q3 2023
Q2Q % growth

-100.00%
765K-765K-100.00%
Q2 2023
Q2Q % growth
3.824M
-58.07%
1.594M2.23M139.90%
Q1 2023
Q2Q % growth
7.014M
-7.47%
2.996M4.018M134.11%
Q4 2022
Q2Q % growth
15.33M
62.05%
7.908M7.422M93.85%
Q3 2022
Q2Q % growth
3.36M
205.45%
6.406M-3.046M-47.55%
Q2 2022
Q2Q % growth
9.12M
4.83%
7.159M1.961M27.39%
Q1 2022
Q2Q % growth
7.58M
-25.17%
8.67M-1.09M-12.57%
Q4 2021
Q2Q % growth
9.46M
8.11%
9.096M364K4.00%
Q3 2021
Q2Q % growth
1.1M
-91.31%
8.874M-7.774M-87.60%
Q2 2021
Q2Q % growth
8.7M
-13.26%
9.571M-871K-9.10%
Q1 2021
Q2Q % growth
10.13M
-12.29%
9.649M481K4.98%
Q4 2020
Q2Q % growth
8.75M
-27.63%
17.116M-8.366M-48.88%
Q3 2020
Q2Q % growth
12.66M
1.20%
14.525M-1.865M-12.84%
Q2 2020
Q2Q % growth
10.03M
-18.32%
13.627M-3.597M-26.40%
Q1 2020
Q2Q % growth
11.55M
-12.30%
13.643M-2.093M-15.34%
Q4 2019
Q2Q % growth
12.09M 13.107M-1.017M-7.76%
RVMD Yearly Revenue VS EstimatesRVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.99% -7.12% 0% -2.41%
Revenue58.29% 21.74% -7.7% -38.46%